IC304-2021: Hype, Promise, and Reality: Orthopedic Use of Biologics in 2021-Hype, Promise, and Reality: Orthopedic Use of Biologics in 2021' (3/4)

Hype, Promise, and Reality: Orthopedic Use of Biologics in 2021' (3/4)

Video Transcription

Video Summary

The video discusses the potential and limitations of orthobiologics in regenerative medicine. The speaker focuses on the use of orthobiologics such as platelet-rich plasma (PRP) and cell therapy for tendinopathy and rotator cuff repair. They discuss the different formulations of PRP and the importance of leukocyte-rich formulations for tendon healing. The speaker also mentions the use of cell therapy, specifically mesenchymal stromal cells derived from bone marrow or adipose tissue, and their potential for improving structural healing. They highlight the heterogeneity in orthobiologic preparations and the need for better methods to measure and classify these products. The speaker concludes by stressing the importance of tailoring therapy to the specific tissue and underlying pathology, as well as the need for further research in the field. No credits were granted in the video.

Asset Caption

Scott Rodeo, MD

Keywords

orthobiologics

regenerative medicine

platelet-rich plasma

cell therapy

tendinopathy

rotator cuff repair